Business
How China’s ancient capital staked a claim to the nation’s fastest export growth
By Katherine Langford
China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates
Marcus Chen
Marcus Chen
Managing Editor · St. Paul, MN
Marcus manages the day-to-day editorial workflow across all brands, coordinating coverage assignments and ensuring editorial standards are met. He previously served as city editor at the Pioneer Press and holds a degree in Political Science from Carleton College.
More from Marcus →Managing Editor · Tuesday, October 27, 2026 at 11:30 AM · 1 min read
Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales. Net profit reached 2.46 billion yuan for the three months ended September 30, jumping 88.92 per cent year on year and exceeding the Bloomberg analyst consensus estimate of 2.38 billion yuan. Improving innovative drug sales and out-licensing revenue...
Up nextHow China’s ancient capital staked a claim to the nation’s fastest export growthBusiness · 1 min read
More Business stories
Business
Over 1,000 still in Japan shelters 3 months after Kumamoto quake: ‘exhausted all the time’
By Katherine Langford
Business
China’s battery factories could be sitting right on top of vast lithium deposits
By Marcus Chen
Business
Why is the US reluctant to give South Korea wartime control of its troops?
By Marcus Chen